Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

Employees

990

Sector

Advanced Medical Equipment & Technology

Calendar

08-19 Earnings release - Q4 2026

More about the company

Quotes

Date	Price	Change	Volume
26-08-07	US$0.2850	+0.81%	993,884
26-08-06	US$0.2827	+3.06%	447,625
26-08-05	US$0.2743	-11.86%	718,791
26-08-04	US$0.3112	+15.34%	1,750,790
26-08-03	US$0.2698	+0.63%	637,341

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.2850USD

Average target price

0.3500USD

Spread / Average Target

+22.81%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-07 EDT			5-day change	1st Jan Change
0.2850 ^USD	+0.81%		+6.30%	-65.44%

07-30	Accuray Enters Agreements With TCW Asset Management to Boost Financial Position, Liquidity	MT
07-29	Accuray Incorporated Announces Board Changes, Effective July 29, 2026	CI

Market Cap	33.9M 29.33M 27.39M 25.12M 47.25M 3.23B 48.01M 321M 126M 1.62B 127M 125M 5.35B	P/E 2026 *	-0.81x	P/E 2027 *	-0.95x
Enterprise Value	33.9M 29.33M 27.39M 25.12M 47.25M 3.23B 48.01M 321M 126M 1.62B 127M 125M 5.35B	EV / Sales 2026 *	0.08x	EV / Sales 2027 *	0.08x
Free-Float	95.66%	Yield 2026 *	-	Yield 2027 *	-

07-30	Accuray Enters Agreements With TCW Asset Management to Boost Financial Position, Liquidity	MT
07-29	Accuray Incorporated Announces Board Changes, Effective July 29, 2026	CI
07-28	Accuray Incorporated announced that it expects to receive $15 million in funding	CI
07-10	Accuray Incorporated Recalls 48 Units Cyberknife Treatment Deliver System Equipped with the Xchange Robotic Collimator Changer	CI
05-29	Accuray Incorporated reports inducement award under Nasdaq Listing Rules	RE
05-15	Accuray Incorporated And University Of Wisconsin School Of Medicine And Public Health Enter Master Research Agreement	CI
05-12	Accuray Shares Fall After Jefferies Downgrade	MT
05-12	Jefferies Downgrades Accuray to Hold From Buy, Adjusts Price Target to $0.35 From $3.50	MT
05-07	BTIG Downgrades Accuray to Neutral From Buy, Price Target is $2	MT
05-07	Accuray Incorporated, Q3 2026 Earnings Call, May 06, 2026
05-06	Accuray Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026	CI
05-06	Accuray Incorporated Withdraws Earnings Guidance for the Fiscal Year 2026	CI
04-28	Accuray Incorporated Announces Departure of Leonel Peralta as Senior Vice President, Chief Operations Officer, Effective April 26, 2026	CI

05-12	Accuray Shares Fall After Jefferies Downgrade	MT
05-12	Jefferies Downgrades Accuray to Hold From Buy, Adjusts Price Target to $0.35 From $3.50	MT
05-07	BTIG Downgrades Accuray to Neutral From Buy, Price Target is $2	MT
24-02-13	Roth MKM Starts Accuray With Buy Rating, $9 Price Target	MT
23-11-09	B. Riley Trims Accuray's Price Target to $6.50 From $7.50 on Lower Multiple, Maintains Buy Rating	MT

Accuray Incorporated Stock

Stocks

ARAY

US0043971052

Advanced Medical Equipment & Technology

Valuation: Accuray Incorporated

Chart: Accuray Incorporated

Latest news : Accuray Incorporated

Last Transcript: Accuray Incorporated

Analysts' recommendations: Accuray Incorporated

Press Releases: Accuray Incorporated

News in other languages: Accuray Incorporated

Quotes and Performance

Course Extremes

Managers and Directors: Accuray Incorporated

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Quarterly revenue - Rate of surprise

08-05	Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026	PR
07-29	Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation	PR
05-29	Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules	PR
05-15	Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer	PR
05-06	Accuray Incorporated : ARAY Q3 FY26 Earnings Call Supplemental Deck FINAL	PU

1 day	+0.81%
1 week	+6.30%
Current month	+6.30%
1 month	+14.41%
3 months	-2.76%
6 months	-54.03%
Current year	-65.44%

1 week	0.26	0.32
1 month	0.22	0.32
Current year	0.22	0.93
1 year	0.22	2.1
3 years	0.22	4.03
5 years	0.22	5.93
10 years	0.22	6.39

Manager	Title	Age	Since
Stephen la Neve CEO	Chief Executive Officer	67	2025-10-19
Ali Pervaiz DFI	Director of Finance/CFO	46	2022-05-08
Mu Young Lee CTO	Chief Tech/Sci/R&D Officer	-	2023-08-31

Director	Title	Age	Since
Joseph Whitters CHM	Chairman	68	2020-12-31
James Hindman BRD	Director/Board Member	65	2019-09-05
Mika Nishimura BRD	Director/Board Member	62	2021-08-16

Date	Insider	Type	Main position	Quantity	% Market Cap.
2/28/26	Leonel Peralta	Fiscal year	Chief Operating Officer	196,415	0.1733%
2/20/26	Steven Mayer	Buy	Director	54,875	0.0484%
2/18/26	Steven Mayer	Buy	Director	195,125	0.1722%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACCURAY INCORPORATED	+0.81%	+6.30%	-78.41%	-93.21%	33.9M
THERMO FISHER SCIENTIFIC, INC.	+2.41%	+3.43%	+30.62%	+7.65%	220B
DANAHER CORPORATION	+2.39%	+5.02%	+3.16%	-19.90%	144B
INTUITIVE SURGICAL, INC.	+1.36%	+7.21%	-19.37%	+22.50%	134B
BOSTON SCIENTIFIC CORPORATION	+0.02%	+5.52%	-52.11%	-2.80%	71.46B
EDWARDS LIFESCIENCES CORPORATION	+0.45%	+4.24%	+15.13%	+12.37%	51.71B
SIEMENS HEALTHINEERS AG	+1.05%	+7.19%	-14.42%	-19.02%	50.84B
AGILENT TECHNOLOGIES, INC.	+3.28%	+5.49%	+28.07%	+15.38%	41.23B
WATERS CORPORATION	+1.79%	+7.83%	+46.35%	+40.43%	39.95B
RESMED, INC.	-5.06%	+0.46%	-24.35%	+13.54%	30.57B
Average	+0.85%	+5.12%	-6.53%	-2.31%	78.32B
Weighted average by Cap.	+1.51%	+4.98%	+4.05%	+5.06%

	2026 *	2027 *
Net sales	406M 351M 328M 301M 566M 38.67B 575M 3.85B 1.51B 19.38B 1.53B 1.49B 64.07B	413M 357M 334M 306M 576M 39.31B 585M 3.91B 1.54B 19.7B 1.55B 1.52B 65.13B
Net income	-42.6M -36.85M -34.41M -31.57M -59.37M -4.05B -60.32M -404M -158M -2.03B -160M -156M -6.72B	-37.9M -32.78M -30.61M -28.08M -52.82M -3.61B -53.66M -359M -141M -1.81B -142M -139M -5.98B
Net Debt	-	-